LAURUS LABS LIMITED
1. IPO DETAILS
COMPANY: LAURUS LABS LIMITED
IPO LOT SIZE: 35 SHARES PER APPLN.
PRICE BAND: INR 426 - INR 428
MIN. APP. SIZE: INR 14,980.00 (NO RET. DISC)
DATE: 6 - 8 DECEMBER 2016
2. Company Background
Incorporated in 2005, Laurus Labs Ltd. is Hyderabad based pharmaceutical
company. Laurus Labs is in the business of manufacturing generic active
pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and
Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.
Company’s strategic and early investments in R&D and manufacturing infrastructure
has enabled it to become one of the leading suppliers of APIs in the ARV
therapeutic area to multi-national pharmaceutical formulation companies which
cater to the large and fast-growing “donor-funded access-to medicines markets” of
Sub-Saharan Africa, South-East Asia and Latin America. During the financial year
2016, LLL sold its APIs in 32 countries. The company also has growing synthesis
and nutraceutical/cosmeceutical ingredients businesses.